DiscoverWSJ What’s NewsModerna, Pfizer Covid-19 Vaccines and the New Tech Behind Them
Moderna, Pfizer Covid-19 Vaccines and the New Tech Behind Them

Moderna, Pfizer Covid-19 Vaccines and the New Tech Behind Them

Update: 2020-11-16
Share

Description

P.M. Edition for Nov. 16. Drugmaker Moderna is the second drugmaker to report success with a Covid-19 vaccine that uses a new, gene-based technology known as messenger RNA. It's part of the reason they've been so fast in developing and testing the vaccines. If they work, the applications of mRNA could go beyond the pandemic. WSJ pharmaceutical reporter Peter Loftus discusses how the technology works. Annmarie Fertoli hosts.

Learn more about your ad choices. Visit megaphone.fm/adchoices

Comments 
Download from Google Play
Download from App Store
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Moderna, Pfizer Covid-19 Vaccines and the New Tech Behind Them

Moderna, Pfizer Covid-19 Vaccines and the New Tech Behind Them

The Wall Street Journal